Global Mycoplasma Testing Supply, Demand and Key Producers, 2026-2032
The global Mycoplasma Testing market size is expected to reach $ 2601 million by 2032, rising at a market growth of 11.7% CAGR during the forecast period (2026-2032).
The gross profit margin of major companies was approximately 45%–68%.
Mycoplasma Testing detects contamination or infection caused by Mycoplasma species using PCR, culture, enzymatic, immunological, or staining methods. It is primarily applied to biopharmaceutical production, cell cultures, vaccines, gene and cell therapies, research samples, and selected clinical specimens. The scope excludes general bacterial testing, endotoxin testing, sterility testing unrelated to Mycoplasma, and contamination-removal services.
The industrial chain includes upstream primers, probes, enzymes, culture media, antibodies, controls, extraction reagents, and analytical instruments. Midstream covers kit manufacturing, sample preparation, amplification, culture, result analysis, quality control, and laboratory services. Downstream users include pharmaceutical companies, biotechnology companies, cell-therapy developers, contract laboratories, research institutions, and hospitals.
Mycoplasma Testing includes products and services used to detect mycoplasma contamination or infection through culture, biochemical analysis, nucleic acid amplification, immunoassays, and other analytical methods. It is widely used in biopharmaceutical manufacturing, cell and gene therapy, vaccine production, cell culture laboratories, clinical diagnosis, and research institutions. In pharmaceutical production, testing helps prevent contaminated cell substrates, raw materials, and biological products from entering downstream processes or being released to market. The industry is moving from traditional culture methods toward rapid PCR, digital PCR, automated sample preparation, high-throughput testing, and validated point-of-use solutions. Growth is driven by expanding biologics and vaccine production, increasing cell and gene therapy pipelines, stricter contamination-control regulations, and greater outsourcing to specialized testing laboratories. Rapid methods are gaining adoption because they shorten testing cycles and accelerate batch release. However, method validation, false-positive risks, matrix interference, laboratory quality requirements, and the relatively high cost of rapid-testing systems remain important constraints.
This report is a detailed and comprehensive analysis of the world market for Mycoplasma Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Mycoplasma Testing that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Mycoplasma Testing market
2. What is the demand of the global Mycoplasma Testing market?
3. What is the year over year growth of the global Mycoplasma Testing market?
4. What is the total value of the global Mycoplasma Testing market?
5. Who are the Major Players in the global Mycoplasma Testing market?
6. What are the growth factors driving the market demand?
The gross profit margin of major companies was approximately 45%–68%.
Mycoplasma Testing detects contamination or infection caused by Mycoplasma species using PCR, culture, enzymatic, immunological, or staining methods. It is primarily applied to biopharmaceutical production, cell cultures, vaccines, gene and cell therapies, research samples, and selected clinical specimens. The scope excludes general bacterial testing, endotoxin testing, sterility testing unrelated to Mycoplasma, and contamination-removal services.
The industrial chain includes upstream primers, probes, enzymes, culture media, antibodies, controls, extraction reagents, and analytical instruments. Midstream covers kit manufacturing, sample preparation, amplification, culture, result analysis, quality control, and laboratory services. Downstream users include pharmaceutical companies, biotechnology companies, cell-therapy developers, contract laboratories, research institutions, and hospitals.
Mycoplasma Testing includes products and services used to detect mycoplasma contamination or infection through culture, biochemical analysis, nucleic acid amplification, immunoassays, and other analytical methods. It is widely used in biopharmaceutical manufacturing, cell and gene therapy, vaccine production, cell culture laboratories, clinical diagnosis, and research institutions. In pharmaceutical production, testing helps prevent contaminated cell substrates, raw materials, and biological products from entering downstream processes or being released to market. The industry is moving from traditional culture methods toward rapid PCR, digital PCR, automated sample preparation, high-throughput testing, and validated point-of-use solutions. Growth is driven by expanding biologics and vaccine production, increasing cell and gene therapy pipelines, stricter contamination-control regulations, and greater outsourcing to specialized testing laboratories. Rapid methods are gaining adoption because they shorten testing cycles and accelerate batch release. However, method validation, false-positive risks, matrix interference, laboratory quality requirements, and the relatively high cost of rapid-testing systems remain important constraints.
Report Scope
This report studies the global Mycoplasma Testing demand, key companies, and key regions.This report is a detailed and comprehensive analysis of the world market for Mycoplasma Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Mycoplasma Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Mycoplasma Testing total market, 2021-2032, (USD Million)
- Global Mycoplasma Testing total market by region & country, CAGR, 2021-2032, (USD Million)
- U.S. VS China: Mycoplasma Testing total market, key domestic companies, and share, (USD Million)
- Global Mycoplasma Testing revenue by player, revenue and market share 2021-2026, (USD Million)
- Global Mycoplasma Testing total market by Type, CAGR, 2021-2032, (USD Million)
- Global Mycoplasma Testing total market by Application, CAGR, 2021-2032, (USD Million)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Mycoplasma Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Mycoplasma Testing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Mycoplasma Testing Market, Segmentation by Type:
- Nucleic Acid Amplification Testing
- Culture-based Testing
- Immunological and Biochemical Testing
Global Mycoplasma Testing Market, Segmentation by Sample Type:
- Clinical Specimen Testing
- Cell Culture Sample Testing
- Biopharmaceutical Process Sample Testing
Global Mycoplasma Testing Market, Segmentation by Turnaround Time:
- Rapid Testing(≤4 Hours)
- Standard Testing(>4–48 Hours)
- Extended Testing(>48 Hours)
Global Mycoplasma Testing Market, Segmentation by Application:
- Clinical Infection Diagnosis
- Cell Culture Contamination Monitoring
- Biopharmaceutical Quality Control
- Other
Companies Profiled:
- Thermo Fisher Scientific Inc.
- Lonza Group AG
- Merck KGaA
- Sartorius AG
- Hologic, Inc.
- Roche Diagnostics
- QIAGEN N.V.
- ATCC
- Promega Corporation
- InvivoGen SAS
- Minerva Biolabs GmbH
- PromoCell GmbH
- Takara Bio Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Shimadzu Diagnostics Corporation
- Seegene Inc.
- Bioneer Corporation
- SolGent Co., Ltd.
- Sansure Biotech Inc.
- Daan Gene Co., Ltd.
- Shanghai ZJ Bio-Tech Co., Ltd.
- Jiangsu Bioperfectus Technologies Co., Ltd.
- Vazyme Biotech Co., Ltd.
- Yeasen Biotechnology (Shanghai) Co., Ltd.
- Beyotime Biotechnology Co., Ltd.
- Shanghai Life-iLab Biotech Co., Ltd.
- Tiangen Biotech (Beijing) Co., Ltd.
- Guangzhou Wondfo Biotech Co., Ltd.
- Guangdong Hybribio Biotech Co., Ltd.
Key Questions Answered
1. How big is the global Mycoplasma Testing market?2. What is the demand of the global Mycoplasma Testing market?
3. What is the year over year growth of the global Mycoplasma Testing market?
4. What is the total value of the global Mycoplasma Testing market?
5. Who are the Major Players in the global Mycoplasma Testing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Mycoplasma Testing Introduction
1.2 World Mycoplasma Testing Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Mycoplasma Testing Total Market by Region (by Headquarter Location)
1.3.1 World Mycoplasma Testing Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Mycoplasma Testing Revenue (2021-2032)
1.3.3 China Based Company Mycoplasma Testing Revenue (2021-2032)
1.3.4 Europe Based Company Mycoplasma Testing Revenue (2021-2032)
1.3.5 Japan Based Company Mycoplasma Testing Revenue (2021-2032)
1.3.6 South Korea Based Company Mycoplasma Testing Revenue (2021-2032)
1.3.7 ASEAN Based Company Mycoplasma Testing Revenue (2021-2032)
1.3.8 India Based Company Mycoplasma Testing Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Mycoplasma Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Mycoplasma Testing Consumption Value (2021-2032)
2.2 World Mycoplasma Testing Consumption Value by Region
2.2.1 World Mycoplasma Testing Consumption Value by Region (2021-2026)
2.2.2 World Mycoplasma Testing Consumption Value Forecast by Region (2027-2032)
2.3 United States Mycoplasma Testing Consumption Value (2021-2032)
2.4 China Mycoplasma Testing Consumption Value (2021-2032)
2.5 Europe Mycoplasma Testing Consumption Value (2021-2032)
2.6 Japan Mycoplasma Testing Consumption Value (2021-2032)
2.7 South Korea Mycoplasma Testing Consumption Value (2021-2032)
2.8 ASEAN Mycoplasma Testing Consumption Value (2021-2032)
2.9 India Mycoplasma Testing Consumption Value (2021-2032)
3 WORLD MYCOPLASMA TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Mycoplasma Testing Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Mycoplasma Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Mycoplasma Testing in 2025
3.2.3 Global Concentration Ratios (CR8) for Mycoplasma Testing in 2025
3.3 Mycoplasma Testing Company Evaluation Quadrant
3.4 Mycoplasma Testing Market: Overall Company Footprint Analysis
3.4.1 Mycoplasma Testing Market: Region Footprint
3.4.2 Mycoplasma Testing Market: Company Product Type Footprint
3.4.3 Mycoplasma Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Mycoplasma Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Mycoplasma Testing Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Mycoplasma Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Mycoplasma Testing Consumption Value Comparison
4.2.1 United States VS China: Mycoplasma Testing Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Mycoplasma Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Mycoplasma Testing Companies and Market Share, 2021-2026
4.3.1 United States Based Mycoplasma Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Mycoplasma Testing Revenue, (2021-2026)
4.4 China Based Companies Mycoplasma Testing Revenue and Market Share, 2021-2026
4.4.1 China Based Mycoplasma Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Mycoplasma Testing Revenue, (2021-2026)
4.5 Rest of World Based Mycoplasma Testing Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Mycoplasma Testing Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Mycoplasma Testing Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Mycoplasma Testing Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Nucleic Acid Amplification Testing
5.2.2 Culture-based Testing
5.2.3 Immunological and Biochemical Testing
5.3 Market Segment by Type
5.3.1 World Mycoplasma Testing Market Size by Type (2021-2026)
5.3.2 World Mycoplasma Testing Market Size by Type (2027-2032)
5.3.3 World Mycoplasma Testing Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SAMPLE TYPE
6.1 World Mycoplasma Testing Market Size Overview by Sample Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sample Type
6.2.1 Clinical Specimen Testing
6.2.2 Cell Culture Sample Testing
6.2.3 Biopharmaceutical Process Sample Testing
6.3 Market Segment by Sample Type
6.3.1 World Mycoplasma Testing Market Size by Sample Type (2021-2026)
6.3.2 World Mycoplasma Testing Market Size by Sample Type (2027-2032)
6.3.3 World Mycoplasma Testing Market Size Market Share by Sample Type (2027-2032)
7 MARKET ANALYSIS BY TURNAROUND TIME
7.1 World Mycoplasma Testing Market Size Overview by Turnaround Time: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Turnaround Time
7.2.1 Rapid Testing(≤4 Hours)
7.2.2 Standard Testing(>4–48 Hours)
7.2.3 Extended Testing(>48 Hours)
7.3 Market Segment by Turnaround Time
7.3.1 World Mycoplasma Testing Market Size by Turnaround Time (2021-2026)
7.3.2 World Mycoplasma Testing Market Size by Turnaround Time (2027-2032)
7.3.3 World Mycoplasma Testing Market Size Market Share by Turnaround Time (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Mycoplasma Testing Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Clinical Infection Diagnosis
8.2.2 Cell Culture Contamination Monitoring
8.2.3 Biopharmaceutical Quality Control
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Mycoplasma Testing Market Size by Application (2021-2026)
8.3.2 World Mycoplasma Testing Market Size by Application (2027-2032)
8.3.3 World Mycoplasma Testing Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Thermo Fisher Scientific Inc.
9.1.1 Thermo Fisher Scientific Inc. Details
9.1.2 Thermo Fisher Scientific Inc. Major Business
9.1.3 Thermo Fisher Scientific Inc. Mycoplasma Testing Product and Services
9.1.4 Thermo Fisher Scientific Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
9.1.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
9.2 Lonza Group AG
9.2.1 Lonza Group AG Details
9.2.2 Lonza Group AG Major Business
9.2.3 Lonza Group AG Mycoplasma Testing Product and Services
9.2.4 Lonza Group AG Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Lonza Group AG Recent Developments/Updates
9.2.6 Lonza Group AG Competitive Strengths & Weaknesses
9.3 Merck KGaA
9.3.1 Merck KGaA Details
9.3.2 Merck KGaA Major Business
9.3.3 Merck KGaA Mycoplasma Testing Product and Services
9.3.4 Merck KGaA Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Merck KGaA Recent Developments/Updates
9.3.6 Merck KGaA Competitive Strengths & Weaknesses
9.4 Sartorius AG
9.4.1 Sartorius AG Details
9.4.2 Sartorius AG Major Business
9.4.3 Sartorius AG Mycoplasma Testing Product and Services
9.4.4 Sartorius AG Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Sartorius AG Recent Developments/Updates
9.4.6 Sartorius AG Competitive Strengths & Weaknesses
9.5 Hologic, Inc.
9.5.1 Hologic, Inc. Details
9.5.2 Hologic, Inc. Major Business
9.5.3 Hologic, Inc. Mycoplasma Testing Product and Services
9.5.4 Hologic, Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Hologic, Inc. Recent Developments/Updates
9.5.6 Hologic, Inc. Competitive Strengths & Weaknesses
9.6 Roche Diagnostics
9.6.1 Roche Diagnostics Details
9.6.2 Roche Diagnostics Major Business
9.6.3 Roche Diagnostics Mycoplasma Testing Product and Services
9.6.4 Roche Diagnostics Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Roche Diagnostics Recent Developments/Updates
9.6.6 Roche Diagnostics Competitive Strengths & Weaknesses
9.7 QIAGEN N.V.
9.7.1 QIAGEN N.V. Details
9.7.2 QIAGEN N.V. Major Business
9.7.3 QIAGEN N.V. Mycoplasma Testing Product and Services
9.7.4 QIAGEN N.V. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 QIAGEN N.V. Recent Developments/Updates
9.7.6 QIAGEN N.V. Competitive Strengths & Weaknesses
9.8 ATCC
9.8.1 ATCC Details
9.8.2 ATCC Major Business
9.8.3 ATCC Mycoplasma Testing Product and Services
9.8.4 ATCC Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 ATCC Recent Developments/Updates
9.8.6 ATCC Competitive Strengths & Weaknesses
9.9 Promega Corporation
9.9.1 Promega Corporation Details
9.9.2 Promega Corporation Major Business
9.9.3 Promega Corporation Mycoplasma Testing Product and Services
9.9.4 Promega Corporation Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Promega Corporation Recent Developments/Updates
9.9.6 Promega Corporation Competitive Strengths & Weaknesses
9.10 InvivoGen SAS
9.10.1 InvivoGen SAS Details
9.10.2 InvivoGen SAS Major Business
9.10.3 InvivoGen SAS Mycoplasma Testing Product and Services
9.10.4 InvivoGen SAS Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 InvivoGen SAS Recent Developments/Updates
9.10.6 InvivoGen SAS Competitive Strengths & Weaknesses
9.11 Minerva Biolabs GmbH
9.11.1 Minerva Biolabs GmbH Details
9.11.2 Minerva Biolabs GmbH Major Business
9.11.3 Minerva Biolabs GmbH Mycoplasma Testing Product and Services
9.11.4 Minerva Biolabs GmbH Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Minerva Biolabs GmbH Recent Developments/Updates
9.11.6 Minerva Biolabs GmbH Competitive Strengths & Weaknesses
9.12 PromoCell GmbH
9.12.1 PromoCell GmbH Details
9.12.2 PromoCell GmbH Major Business
9.12.3 PromoCell GmbH Mycoplasma Testing Product and Services
9.12.4 PromoCell GmbH Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 PromoCell GmbH Recent Developments/Updates
9.12.6 PromoCell GmbH Competitive Strengths & Weaknesses
9.13 Takara Bio Inc.
9.13.1 Takara Bio Inc. Details
9.13.2 Takara Bio Inc. Major Business
9.13.3 Takara Bio Inc. Mycoplasma Testing Product and Services
9.13.4 Takara Bio Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Takara Bio Inc. Recent Developments/Updates
9.13.6 Takara Bio Inc. Competitive Strengths & Weaknesses
9.14 Otsuka Pharmaceutical Co., Ltd.
9.14.1 Otsuka Pharmaceutical Co., Ltd. Details
9.14.2 Otsuka Pharmaceutical Co., Ltd. Major Business
9.14.3 Otsuka Pharmaceutical Co., Ltd. Mycoplasma Testing Product and Services
9.14.4 Otsuka Pharmaceutical Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
9.14.6 Otsuka Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9.15 Shimadzu Diagnostics Corporation
9.15.1 Shimadzu Diagnostics Corporation Details
9.15.2 Shimadzu Diagnostics Corporation Major Business
9.15.3 Shimadzu Diagnostics Corporation Mycoplasma Testing Product and Services
9.15.4 Shimadzu Diagnostics Corporation Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Shimadzu Diagnostics Corporation Recent Developments/Updates
9.15.6 Shimadzu Diagnostics Corporation Competitive Strengths & Weaknesses
9.16 Seegene Inc.
9.16.1 Seegene Inc. Details
9.16.2 Seegene Inc. Major Business
9.16.3 Seegene Inc. Mycoplasma Testing Product and Services
9.16.4 Seegene Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Seegene Inc. Recent Developments/Updates
9.16.6 Seegene Inc. Competitive Strengths & Weaknesses
9.17 Bioneer Corporation
9.17.1 Bioneer Corporation Details
9.17.2 Bioneer Corporation Major Business
9.17.3 Bioneer Corporation Mycoplasma Testing Product and Services
9.17.4 Bioneer Corporation Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Bioneer Corporation Recent Developments/Updates
9.17.6 Bioneer Corporation Competitive Strengths & Weaknesses
9.18 SolGent Co., Ltd.
9.18.1 SolGent Co., Ltd. Details
9.18.2 SolGent Co., Ltd. Major Business
9.18.3 SolGent Co., Ltd. Mycoplasma Testing Product and Services
9.18.4 SolGent Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 SolGent Co., Ltd. Recent Developments/Updates
9.18.6 SolGent Co., Ltd. Competitive Strengths & Weaknesses
9.19 Sansure Biotech Inc.
9.19.1 Sansure Biotech Inc. Details
9.19.2 Sansure Biotech Inc. Major Business
9.19.3 Sansure Biotech Inc. Mycoplasma Testing Product and Services
9.19.4 Sansure Biotech Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Sansure Biotech Inc. Recent Developments/Updates
9.19.6 Sansure Biotech Inc. Competitive Strengths & Weaknesses
9.20 Daan Gene Co., Ltd.
9.20.1 Daan Gene Co., Ltd. Details
9.20.2 Daan Gene Co., Ltd. Major Business
9.20.3 Daan Gene Co., Ltd. Mycoplasma Testing Product and Services
9.20.4 Daan Gene Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Daan Gene Co., Ltd. Recent Developments/Updates
9.20.6 Daan Gene Co., Ltd. Competitive Strengths & Weaknesses
9.21 Shanghai ZJ Bio-Tech Co., Ltd.
9.21.1 Shanghai ZJ Bio-Tech Co., Ltd. Details
9.21.2 Shanghai ZJ Bio-Tech Co., Ltd. Major Business
9.21.3 Shanghai ZJ Bio-Tech Co., Ltd. Mycoplasma Testing Product and Services
9.21.4 Shanghai ZJ Bio-Tech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Shanghai ZJ Bio-Tech Co., Ltd. Recent Developments/Updates
9.21.6 Shanghai ZJ Bio-Tech Co., Ltd. Competitive Strengths & Weaknesses
9.22 Jiangsu Bioperfectus Technologies Co., Ltd.
9.22.1 Jiangsu Bioperfectus Technologies Co., Ltd. Details
9.22.2 Jiangsu Bioperfectus Technologies Co., Ltd. Major Business
9.22.3 Jiangsu Bioperfectus Technologies Co., Ltd. Mycoplasma Testing Product and Services
9.22.4 Jiangsu Bioperfectus Technologies Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Jiangsu Bioperfectus Technologies Co., Ltd. Recent Developments/Updates
9.22.6 Jiangsu Bioperfectus Technologies Co., Ltd. Competitive Strengths & Weaknesses
9.23 Vazyme Biotech Co., Ltd.
9.23.1 Vazyme Biotech Co., Ltd. Details
9.23.2 Vazyme Biotech Co., Ltd. Major Business
9.23.3 Vazyme Biotech Co., Ltd. Mycoplasma Testing Product and Services
9.23.4 Vazyme Biotech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Vazyme Biotech Co., Ltd. Recent Developments/Updates
9.23.6 Vazyme Biotech Co., Ltd. Competitive Strengths & Weaknesses
9.24 Yeasen Biotechnology (Shanghai) Co., Ltd.
9.24.1 Yeasen Biotechnology (Shanghai) Co., Ltd. Details
9.24.2 Yeasen Biotechnology (Shanghai) Co., Ltd. Major Business
9.24.3 Yeasen Biotechnology (Shanghai) Co., Ltd. Mycoplasma Testing Product and Services
9.24.4 Yeasen Biotechnology (Shanghai) Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Yeasen Biotechnology (Shanghai) Co., Ltd. Recent Developments/Updates
9.24.6 Yeasen Biotechnology (Shanghai) Co., Ltd. Competitive Strengths & Weaknesses
9.25 Beyotime Biotechnology Co., Ltd.
9.25.1 Beyotime Biotechnology Co., Ltd. Details
9.25.2 Beyotime Biotechnology Co., Ltd. Major Business
9.25.3 Beyotime Biotechnology Co., Ltd. Mycoplasma Testing Product and Services
9.25.4 Beyotime Biotechnology Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 Beyotime Biotechnology Co., Ltd. Recent Developments/Updates
9.25.6 Beyotime Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
9.26 Shanghai Life-iLab Biotech Co., Ltd.
9.26.1 Shanghai Life-iLab Biotech Co., Ltd. Details
9.26.2 Shanghai Life-iLab Biotech Co., Ltd. Major Business
9.26.3 Shanghai Life-iLab Biotech Co., Ltd. Mycoplasma Testing Product and Services
9.26.4 Shanghai Life-iLab Biotech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 Shanghai Life-iLab Biotech Co., Ltd. Recent Developments/Updates
9.26.6 Shanghai Life-iLab Biotech Co., Ltd. Competitive Strengths & Weaknesses
9.27 Tiangen Biotech (Beijing) Co., Ltd.
9.27.1 Tiangen Biotech (Beijing) Co., Ltd. Details
9.27.2 Tiangen Biotech (Beijing) Co., Ltd. Major Business
9.27.3 Tiangen Biotech (Beijing) Co., Ltd. Mycoplasma Testing Product and Services
9.27.4 Tiangen Biotech (Beijing) Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Tiangen Biotech (Beijing) Co., Ltd. Recent Developments/Updates
9.27.6 Tiangen Biotech (Beijing) Co., Ltd. Competitive Strengths & Weaknesses
9.28 Guangzhou Wondfo Biotech Co., Ltd.
9.28.1 Guangzhou Wondfo Biotech Co., Ltd. Details
9.28.2 Guangzhou Wondfo Biotech Co., Ltd. Major Business
9.28.3 Guangzhou Wondfo Biotech Co., Ltd. Mycoplasma Testing Product and Services
9.28.4 Guangzhou Wondfo Biotech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Guangzhou Wondfo Biotech Co., Ltd. Recent Developments/Updates
9.28.6 Guangzhou Wondfo Biotech Co., Ltd. Competitive Strengths & Weaknesses
9.29 Guangdong Hybribio Biotech Co., Ltd.
9.29.1 Guangdong Hybribio Biotech Co., Ltd. Details
9.29.2 Guangdong Hybribio Biotech Co., Ltd. Major Business
9.29.3 Guangdong Hybribio Biotech Co., Ltd. Mycoplasma Testing Product and Services
9.29.4 Guangdong Hybribio Biotech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 Guangdong Hybribio Biotech Co., Ltd. Recent Developments/Updates
9.29.6 Guangdong Hybribio Biotech Co., Ltd. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Mycoplasma Testing Industry Chain
10.2 Mycoplasma Testing Upstream Analysis
10.3 Mycoplasma Testing Midstream Analysis
10.4 Mycoplasma Testing Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Mycoplasma Testing Introduction
1.2 World Mycoplasma Testing Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Mycoplasma Testing Total Market by Region (by Headquarter Location)
1.3.1 World Mycoplasma Testing Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Mycoplasma Testing Revenue (2021-2032)
1.3.3 China Based Company Mycoplasma Testing Revenue (2021-2032)
1.3.4 Europe Based Company Mycoplasma Testing Revenue (2021-2032)
1.3.5 Japan Based Company Mycoplasma Testing Revenue (2021-2032)
1.3.6 South Korea Based Company Mycoplasma Testing Revenue (2021-2032)
1.3.7 ASEAN Based Company Mycoplasma Testing Revenue (2021-2032)
1.3.8 India Based Company Mycoplasma Testing Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Mycoplasma Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Mycoplasma Testing Consumption Value (2021-2032)
2.2 World Mycoplasma Testing Consumption Value by Region
2.2.1 World Mycoplasma Testing Consumption Value by Region (2021-2026)
2.2.2 World Mycoplasma Testing Consumption Value Forecast by Region (2027-2032)
2.3 United States Mycoplasma Testing Consumption Value (2021-2032)
2.4 China Mycoplasma Testing Consumption Value (2021-2032)
2.5 Europe Mycoplasma Testing Consumption Value (2021-2032)
2.6 Japan Mycoplasma Testing Consumption Value (2021-2032)
2.7 South Korea Mycoplasma Testing Consumption Value (2021-2032)
2.8 ASEAN Mycoplasma Testing Consumption Value (2021-2032)
2.9 India Mycoplasma Testing Consumption Value (2021-2032)
3 WORLD MYCOPLASMA TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Mycoplasma Testing Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Mycoplasma Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Mycoplasma Testing in 2025
3.2.3 Global Concentration Ratios (CR8) for Mycoplasma Testing in 2025
3.3 Mycoplasma Testing Company Evaluation Quadrant
3.4 Mycoplasma Testing Market: Overall Company Footprint Analysis
3.4.1 Mycoplasma Testing Market: Region Footprint
3.4.2 Mycoplasma Testing Market: Company Product Type Footprint
3.4.3 Mycoplasma Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Mycoplasma Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Mycoplasma Testing Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Mycoplasma Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Mycoplasma Testing Consumption Value Comparison
4.2.1 United States VS China: Mycoplasma Testing Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Mycoplasma Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Mycoplasma Testing Companies and Market Share, 2021-2026
4.3.1 United States Based Mycoplasma Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Mycoplasma Testing Revenue, (2021-2026)
4.4 China Based Companies Mycoplasma Testing Revenue and Market Share, 2021-2026
4.4.1 China Based Mycoplasma Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Mycoplasma Testing Revenue, (2021-2026)
4.5 Rest of World Based Mycoplasma Testing Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Mycoplasma Testing Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Mycoplasma Testing Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Mycoplasma Testing Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Nucleic Acid Amplification Testing
5.2.2 Culture-based Testing
5.2.3 Immunological and Biochemical Testing
5.3 Market Segment by Type
5.3.1 World Mycoplasma Testing Market Size by Type (2021-2026)
5.3.2 World Mycoplasma Testing Market Size by Type (2027-2032)
5.3.3 World Mycoplasma Testing Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SAMPLE TYPE
6.1 World Mycoplasma Testing Market Size Overview by Sample Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sample Type
6.2.1 Clinical Specimen Testing
6.2.2 Cell Culture Sample Testing
6.2.3 Biopharmaceutical Process Sample Testing
6.3 Market Segment by Sample Type
6.3.1 World Mycoplasma Testing Market Size by Sample Type (2021-2026)
6.3.2 World Mycoplasma Testing Market Size by Sample Type (2027-2032)
6.3.3 World Mycoplasma Testing Market Size Market Share by Sample Type (2027-2032)
7 MARKET ANALYSIS BY TURNAROUND TIME
7.1 World Mycoplasma Testing Market Size Overview by Turnaround Time: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Turnaround Time
7.2.1 Rapid Testing(≤4 Hours)
7.2.2 Standard Testing(>4–48 Hours)
7.2.3 Extended Testing(>48 Hours)
7.3 Market Segment by Turnaround Time
7.3.1 World Mycoplasma Testing Market Size by Turnaround Time (2021-2026)
7.3.2 World Mycoplasma Testing Market Size by Turnaround Time (2027-2032)
7.3.3 World Mycoplasma Testing Market Size Market Share by Turnaround Time (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Mycoplasma Testing Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Clinical Infection Diagnosis
8.2.2 Cell Culture Contamination Monitoring
8.2.3 Biopharmaceutical Quality Control
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Mycoplasma Testing Market Size by Application (2021-2026)
8.3.2 World Mycoplasma Testing Market Size by Application (2027-2032)
8.3.3 World Mycoplasma Testing Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Thermo Fisher Scientific Inc.
9.1.1 Thermo Fisher Scientific Inc. Details
9.1.2 Thermo Fisher Scientific Inc. Major Business
9.1.3 Thermo Fisher Scientific Inc. Mycoplasma Testing Product and Services
9.1.4 Thermo Fisher Scientific Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
9.1.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
9.2 Lonza Group AG
9.2.1 Lonza Group AG Details
9.2.2 Lonza Group AG Major Business
9.2.3 Lonza Group AG Mycoplasma Testing Product and Services
9.2.4 Lonza Group AG Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Lonza Group AG Recent Developments/Updates
9.2.6 Lonza Group AG Competitive Strengths & Weaknesses
9.3 Merck KGaA
9.3.1 Merck KGaA Details
9.3.2 Merck KGaA Major Business
9.3.3 Merck KGaA Mycoplasma Testing Product and Services
9.3.4 Merck KGaA Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Merck KGaA Recent Developments/Updates
9.3.6 Merck KGaA Competitive Strengths & Weaknesses
9.4 Sartorius AG
9.4.1 Sartorius AG Details
9.4.2 Sartorius AG Major Business
9.4.3 Sartorius AG Mycoplasma Testing Product and Services
9.4.4 Sartorius AG Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Sartorius AG Recent Developments/Updates
9.4.6 Sartorius AG Competitive Strengths & Weaknesses
9.5 Hologic, Inc.
9.5.1 Hologic, Inc. Details
9.5.2 Hologic, Inc. Major Business
9.5.3 Hologic, Inc. Mycoplasma Testing Product and Services
9.5.4 Hologic, Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Hologic, Inc. Recent Developments/Updates
9.5.6 Hologic, Inc. Competitive Strengths & Weaknesses
9.6 Roche Diagnostics
9.6.1 Roche Diagnostics Details
9.6.2 Roche Diagnostics Major Business
9.6.3 Roche Diagnostics Mycoplasma Testing Product and Services
9.6.4 Roche Diagnostics Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Roche Diagnostics Recent Developments/Updates
9.6.6 Roche Diagnostics Competitive Strengths & Weaknesses
9.7 QIAGEN N.V.
9.7.1 QIAGEN N.V. Details
9.7.2 QIAGEN N.V. Major Business
9.7.3 QIAGEN N.V. Mycoplasma Testing Product and Services
9.7.4 QIAGEN N.V. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 QIAGEN N.V. Recent Developments/Updates
9.7.6 QIAGEN N.V. Competitive Strengths & Weaknesses
9.8 ATCC
9.8.1 ATCC Details
9.8.2 ATCC Major Business
9.8.3 ATCC Mycoplasma Testing Product and Services
9.8.4 ATCC Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 ATCC Recent Developments/Updates
9.8.6 ATCC Competitive Strengths & Weaknesses
9.9 Promega Corporation
9.9.1 Promega Corporation Details
9.9.2 Promega Corporation Major Business
9.9.3 Promega Corporation Mycoplasma Testing Product and Services
9.9.4 Promega Corporation Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Promega Corporation Recent Developments/Updates
9.9.6 Promega Corporation Competitive Strengths & Weaknesses
9.10 InvivoGen SAS
9.10.1 InvivoGen SAS Details
9.10.2 InvivoGen SAS Major Business
9.10.3 InvivoGen SAS Mycoplasma Testing Product and Services
9.10.4 InvivoGen SAS Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 InvivoGen SAS Recent Developments/Updates
9.10.6 InvivoGen SAS Competitive Strengths & Weaknesses
9.11 Minerva Biolabs GmbH
9.11.1 Minerva Biolabs GmbH Details
9.11.2 Minerva Biolabs GmbH Major Business
9.11.3 Minerva Biolabs GmbH Mycoplasma Testing Product and Services
9.11.4 Minerva Biolabs GmbH Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Minerva Biolabs GmbH Recent Developments/Updates
9.11.6 Minerva Biolabs GmbH Competitive Strengths & Weaknesses
9.12 PromoCell GmbH
9.12.1 PromoCell GmbH Details
9.12.2 PromoCell GmbH Major Business
9.12.3 PromoCell GmbH Mycoplasma Testing Product and Services
9.12.4 PromoCell GmbH Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 PromoCell GmbH Recent Developments/Updates
9.12.6 PromoCell GmbH Competitive Strengths & Weaknesses
9.13 Takara Bio Inc.
9.13.1 Takara Bio Inc. Details
9.13.2 Takara Bio Inc. Major Business
9.13.3 Takara Bio Inc. Mycoplasma Testing Product and Services
9.13.4 Takara Bio Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Takara Bio Inc. Recent Developments/Updates
9.13.6 Takara Bio Inc. Competitive Strengths & Weaknesses
9.14 Otsuka Pharmaceutical Co., Ltd.
9.14.1 Otsuka Pharmaceutical Co., Ltd. Details
9.14.2 Otsuka Pharmaceutical Co., Ltd. Major Business
9.14.3 Otsuka Pharmaceutical Co., Ltd. Mycoplasma Testing Product and Services
9.14.4 Otsuka Pharmaceutical Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
9.14.6 Otsuka Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9.15 Shimadzu Diagnostics Corporation
9.15.1 Shimadzu Diagnostics Corporation Details
9.15.2 Shimadzu Diagnostics Corporation Major Business
9.15.3 Shimadzu Diagnostics Corporation Mycoplasma Testing Product and Services
9.15.4 Shimadzu Diagnostics Corporation Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Shimadzu Diagnostics Corporation Recent Developments/Updates
9.15.6 Shimadzu Diagnostics Corporation Competitive Strengths & Weaknesses
9.16 Seegene Inc.
9.16.1 Seegene Inc. Details
9.16.2 Seegene Inc. Major Business
9.16.3 Seegene Inc. Mycoplasma Testing Product and Services
9.16.4 Seegene Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Seegene Inc. Recent Developments/Updates
9.16.6 Seegene Inc. Competitive Strengths & Weaknesses
9.17 Bioneer Corporation
9.17.1 Bioneer Corporation Details
9.17.2 Bioneer Corporation Major Business
9.17.3 Bioneer Corporation Mycoplasma Testing Product and Services
9.17.4 Bioneer Corporation Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Bioneer Corporation Recent Developments/Updates
9.17.6 Bioneer Corporation Competitive Strengths & Weaknesses
9.18 SolGent Co., Ltd.
9.18.1 SolGent Co., Ltd. Details
9.18.2 SolGent Co., Ltd. Major Business
9.18.3 SolGent Co., Ltd. Mycoplasma Testing Product and Services
9.18.4 SolGent Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 SolGent Co., Ltd. Recent Developments/Updates
9.18.6 SolGent Co., Ltd. Competitive Strengths & Weaknesses
9.19 Sansure Biotech Inc.
9.19.1 Sansure Biotech Inc. Details
9.19.2 Sansure Biotech Inc. Major Business
9.19.3 Sansure Biotech Inc. Mycoplasma Testing Product and Services
9.19.4 Sansure Biotech Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Sansure Biotech Inc. Recent Developments/Updates
9.19.6 Sansure Biotech Inc. Competitive Strengths & Weaknesses
9.20 Daan Gene Co., Ltd.
9.20.1 Daan Gene Co., Ltd. Details
9.20.2 Daan Gene Co., Ltd. Major Business
9.20.3 Daan Gene Co., Ltd. Mycoplasma Testing Product and Services
9.20.4 Daan Gene Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Daan Gene Co., Ltd. Recent Developments/Updates
9.20.6 Daan Gene Co., Ltd. Competitive Strengths & Weaknesses
9.21 Shanghai ZJ Bio-Tech Co., Ltd.
9.21.1 Shanghai ZJ Bio-Tech Co., Ltd. Details
9.21.2 Shanghai ZJ Bio-Tech Co., Ltd. Major Business
9.21.3 Shanghai ZJ Bio-Tech Co., Ltd. Mycoplasma Testing Product and Services
9.21.4 Shanghai ZJ Bio-Tech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Shanghai ZJ Bio-Tech Co., Ltd. Recent Developments/Updates
9.21.6 Shanghai ZJ Bio-Tech Co., Ltd. Competitive Strengths & Weaknesses
9.22 Jiangsu Bioperfectus Technologies Co., Ltd.
9.22.1 Jiangsu Bioperfectus Technologies Co., Ltd. Details
9.22.2 Jiangsu Bioperfectus Technologies Co., Ltd. Major Business
9.22.3 Jiangsu Bioperfectus Technologies Co., Ltd. Mycoplasma Testing Product and Services
9.22.4 Jiangsu Bioperfectus Technologies Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Jiangsu Bioperfectus Technologies Co., Ltd. Recent Developments/Updates
9.22.6 Jiangsu Bioperfectus Technologies Co., Ltd. Competitive Strengths & Weaknesses
9.23 Vazyme Biotech Co., Ltd.
9.23.1 Vazyme Biotech Co., Ltd. Details
9.23.2 Vazyme Biotech Co., Ltd. Major Business
9.23.3 Vazyme Biotech Co., Ltd. Mycoplasma Testing Product and Services
9.23.4 Vazyme Biotech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Vazyme Biotech Co., Ltd. Recent Developments/Updates
9.23.6 Vazyme Biotech Co., Ltd. Competitive Strengths & Weaknesses
9.24 Yeasen Biotechnology (Shanghai) Co., Ltd.
9.24.1 Yeasen Biotechnology (Shanghai) Co., Ltd. Details
9.24.2 Yeasen Biotechnology (Shanghai) Co., Ltd. Major Business
9.24.3 Yeasen Biotechnology (Shanghai) Co., Ltd. Mycoplasma Testing Product and Services
9.24.4 Yeasen Biotechnology (Shanghai) Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Yeasen Biotechnology (Shanghai) Co., Ltd. Recent Developments/Updates
9.24.6 Yeasen Biotechnology (Shanghai) Co., Ltd. Competitive Strengths & Weaknesses
9.25 Beyotime Biotechnology Co., Ltd.
9.25.1 Beyotime Biotechnology Co., Ltd. Details
9.25.2 Beyotime Biotechnology Co., Ltd. Major Business
9.25.3 Beyotime Biotechnology Co., Ltd. Mycoplasma Testing Product and Services
9.25.4 Beyotime Biotechnology Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 Beyotime Biotechnology Co., Ltd. Recent Developments/Updates
9.25.6 Beyotime Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
9.26 Shanghai Life-iLab Biotech Co., Ltd.
9.26.1 Shanghai Life-iLab Biotech Co., Ltd. Details
9.26.2 Shanghai Life-iLab Biotech Co., Ltd. Major Business
9.26.3 Shanghai Life-iLab Biotech Co., Ltd. Mycoplasma Testing Product and Services
9.26.4 Shanghai Life-iLab Biotech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 Shanghai Life-iLab Biotech Co., Ltd. Recent Developments/Updates
9.26.6 Shanghai Life-iLab Biotech Co., Ltd. Competitive Strengths & Weaknesses
9.27 Tiangen Biotech (Beijing) Co., Ltd.
9.27.1 Tiangen Biotech (Beijing) Co., Ltd. Details
9.27.2 Tiangen Biotech (Beijing) Co., Ltd. Major Business
9.27.3 Tiangen Biotech (Beijing) Co., Ltd. Mycoplasma Testing Product and Services
9.27.4 Tiangen Biotech (Beijing) Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Tiangen Biotech (Beijing) Co., Ltd. Recent Developments/Updates
9.27.6 Tiangen Biotech (Beijing) Co., Ltd. Competitive Strengths & Weaknesses
9.28 Guangzhou Wondfo Biotech Co., Ltd.
9.28.1 Guangzhou Wondfo Biotech Co., Ltd. Details
9.28.2 Guangzhou Wondfo Biotech Co., Ltd. Major Business
9.28.3 Guangzhou Wondfo Biotech Co., Ltd. Mycoplasma Testing Product and Services
9.28.4 Guangzhou Wondfo Biotech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Guangzhou Wondfo Biotech Co., Ltd. Recent Developments/Updates
9.28.6 Guangzhou Wondfo Biotech Co., Ltd. Competitive Strengths & Weaknesses
9.29 Guangdong Hybribio Biotech Co., Ltd.
9.29.1 Guangdong Hybribio Biotech Co., Ltd. Details
9.29.2 Guangdong Hybribio Biotech Co., Ltd. Major Business
9.29.3 Guangdong Hybribio Biotech Co., Ltd. Mycoplasma Testing Product and Services
9.29.4 Guangdong Hybribio Biotech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 Guangdong Hybribio Biotech Co., Ltd. Recent Developments/Updates
9.29.6 Guangdong Hybribio Biotech Co., Ltd. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Mycoplasma Testing Industry Chain
10.2 Mycoplasma Testing Upstream Analysis
10.3 Mycoplasma Testing Midstream Analysis
10.4 Mycoplasma Testing Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Mycoplasma Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Mycoplasma Testing Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Mycoplasma Testing Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Mycoplasma Testing Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Mycoplasma Testing Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Mycoplasma Testing Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Mycoplasma Testing Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Mycoplasma Testing Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Mycoplasma Testing Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Mycoplasma Testing Players in 2025
Table 12. World Mycoplasma Testing Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Mycoplasma Testing Company Evaluation Quadrant
Table 14. Head Office of Key Mycoplasma Testing Players
Table 15. Mycoplasma Testing Market: Company Product Type Footprint
Table 16. Mycoplasma Testing Market: Company Product Application Footprint
Table 17. Mycoplasma Testing Mergers & Acquisitions Activity
Table 18. United States VS China Mycoplasma Testing Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Mycoplasma Testing Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Mycoplasma Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Mycoplasma Testing Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Mycoplasma Testing Revenue Market Share (2021-2026)
Table 23. China Based Mycoplasma Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Mycoplasma Testing Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Mycoplasma Testing Revenue Market Share (2021-2026)
Table 26. Rest of World Based Mycoplasma Testing Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Mycoplasma Testing Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Mycoplasma Testing Revenue Market Share (2021-2026)
Table 29. World Mycoplasma Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Mycoplasma Testing Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Mycoplasma Testing Market Size by Type (2027-2032) & (USD Million)
Table 32. World Mycoplasma Testing Market Size by Sample Type, (USD Million), 2021 & 2025 & 2032
Table 33. World Mycoplasma Testing Market Size Value by Sample Type (2021-2026) & (USD Million)
Table 34. World Mycoplasma Testing Market Size by Sample Type (2027-2032) & (USD Million)
Table 35. World Mycoplasma Testing Market Size by Turnaround Time, (USD Million), 2021 & 2025 & 2032
Table 36. World Mycoplasma Testing Market Size Value by Turnaround Time (2021-2026) & (USD Million)
Table 37. World Mycoplasma Testing Market Size by Turnaround Time (2027-2032) & (USD Million)
Table 38. World Mycoplasma Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Mycoplasma Testing Market Size by Application (2021-2026) & (USD Million)
Table 40. World Mycoplasma Testing Market Size by Application (2027-2032) & (USD Million)
Table 41. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 42. Thermo Fisher Scientific Inc. Major Business
Table 43. Thermo Fisher Scientific Inc. Mycoplasma Testing Product and Services
Table 44. Thermo Fisher Scientific Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 46. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 47. Lonza Group AG Basic Information, Manufacturing Base and Competitors
Table 48. Lonza Group AG Major Business
Table 49. Lonza Group AG Mycoplasma Testing Product and Services
Table 50. Lonza Group AG Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Lonza Group AG Recent Developments/Updates
Table 52. Lonza Group AG Competitive Strengths & Weaknesses
Table 53. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 54. Merck KGaA Major Business
Table 55. Merck KGaA Mycoplasma Testing Product and Services
Table 56. Merck KGaA Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Merck KGaA Recent Developments/Updates
Table 58. Merck KGaA Competitive Strengths & Weaknesses
Table 59. Sartorius AG Basic Information, Manufacturing Base and Competitors
Table 60. Sartorius AG Major Business
Table 61. Sartorius AG Mycoplasma Testing Product and Services
Table 62. Sartorius AG Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Sartorius AG Recent Developments/Updates
Table 64. Sartorius AG Competitive Strengths & Weaknesses
Table 65. Hologic, Inc. Basic Information, Manufacturing Base and Competitors
Table 66. Hologic, Inc. Major Business
Table 67. Hologic, Inc. Mycoplasma Testing Product and Services
Table 68. Hologic, Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Hologic, Inc. Recent Developments/Updates
Table 70. Hologic, Inc. Competitive Strengths & Weaknesses
Table 71. Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table 72. Roche Diagnostics Major Business
Table 73. Roche Diagnostics Mycoplasma Testing Product and Services
Table 74. Roche Diagnostics Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Roche Diagnostics Recent Developments/Updates
Table 76. Roche Diagnostics Competitive Strengths & Weaknesses
Table 77. QIAGEN N.V. Basic Information, Manufacturing Base and Competitors
Table 78. QIAGEN N.V. Major Business
Table 79. QIAGEN N.V. Mycoplasma Testing Product and Services
Table 80. QIAGEN N.V. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. QIAGEN N.V. Recent Developments/Updates
Table 82. QIAGEN N.V. Competitive Strengths & Weaknesses
Table 83. ATCC Basic Information, Manufacturing Base and Competitors
Table 84. ATCC Major Business
Table 85. ATCC Mycoplasma Testing Product and Services
Table 86. ATCC Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. ATCC Recent Developments/Updates
Table 88. ATCC Competitive Strengths & Weaknesses
Table 89. Promega Corporation Basic Information, Manufacturing Base and Competitors
Table 90. Promega Corporation Major Business
Table 91. Promega Corporation Mycoplasma Testing Product and Services
Table 92. Promega Corporation Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Promega Corporation Recent Developments/Updates
Table 94. Promega Corporation Competitive Strengths & Weaknesses
Table 95. InvivoGen SAS Basic Information, Manufacturing Base and Competitors
Table 96. InvivoGen SAS Major Business
Table 97. InvivoGen SAS Mycoplasma Testing Product and Services
Table 98. InvivoGen SAS Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. InvivoGen SAS Recent Developments/Updates
Table 100. InvivoGen SAS Competitive Strengths & Weaknesses
Table 101. Minerva Biolabs GmbH Basic Information, Manufacturing Base and Competitors
Table 102. Minerva Biolabs GmbH Major Business
Table 103. Minerva Biolabs GmbH Mycoplasma Testing Product and Services
Table 104. Minerva Biolabs GmbH Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Minerva Biolabs GmbH Recent Developments/Updates
Table 106. Minerva Biolabs GmbH Competitive Strengths & Weaknesses
Table 107. PromoCell GmbH Basic Information, Manufacturing Base and Competitors
Table 108. PromoCell GmbH Major Business
Table 109. PromoCell GmbH Mycoplasma Testing Product and Services
Table 110. PromoCell GmbH Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. PromoCell GmbH Recent Developments/Updates
Table 112. PromoCell GmbH Competitive Strengths & Weaknesses
Table 113. Takara Bio Inc. Basic Information, Manufacturing Base and Competitors
Table 114. Takara Bio Inc. Major Business
Table 115. Takara Bio Inc. Mycoplasma Testing Product and Services
Table 116. Takara Bio Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Takara Bio Inc. Recent Developments/Updates
Table 118. Takara Bio Inc. Competitive Strengths & Weaknesses
Table 119. Otsuka Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 120. Otsuka Pharmaceutical Co., Ltd. Major Business
Table 121. Otsuka Pharmaceutical Co., Ltd. Mycoplasma Testing Product and Services
Table 122. Otsuka Pharmaceutical Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 124. Otsuka Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 125. Shimadzu Diagnostics Corporation Basic Information, Manufacturing Base and Competitors
Table 126. Shimadzu Diagnostics Corporation Major Business
Table 127. Shimadzu Diagnostics Corporation Mycoplasma Testing Product and Services
Table 128. Shimadzu Diagnostics Corporation Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Shimadzu Diagnostics Corporation Recent Developments/Updates
Table 130. Shimadzu Diagnostics Corporation Competitive Strengths & Weaknesses
Table 131. Seegene Inc. Basic Information, Manufacturing Base and Competitors
Table 132. Seegene Inc. Major Business
Table 133. Seegene Inc. Mycoplasma Testing Product and Services
Table 134. Seegene Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Seegene Inc. Recent Developments/Updates
Table 136. Seegene Inc. Competitive Strengths & Weaknesses
Table 137. Bioneer Corporation Basic Information, Manufacturing Base and Competitors
Table 138. Bioneer Corporation Major Business
Table 139. Bioneer Corporation Mycoplasma Testing Product and Services
Table 140. Bioneer Corporation Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Bioneer Corporation Recent Developments/Updates
Table 142. Bioneer Corporation Competitive Strengths & Weaknesses
Table 143. SolGent Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 144. SolGent Co., Ltd. Major Business
Table 145. SolGent Co., Ltd. Mycoplasma Testing Product and Services
Table 146. SolGent Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. SolGent Co., Ltd. Recent Developments/Updates
Table 148. SolGent Co., Ltd. Competitive Strengths & Weaknesses
Table 149. Sansure Biotech Inc. Basic Information, Manufacturing Base and Competitors
Table 150. Sansure Biotech Inc. Major Business
Table 151. Sansure Biotech Inc. Mycoplasma Testing Product and Services
Table 152. Sansure Biotech Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Sansure Biotech Inc. Recent Developments/Updates
Table 154. Sansure Biotech Inc. Competitive Strengths & Weaknesses
Table 155. Daan Gene Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 156. Daan Gene Co., Ltd. Major Business
Table 157. Daan Gene Co., Ltd. Mycoplasma Testing Product and Services
Table 158. Daan Gene Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Daan Gene Co., Ltd. Recent Developments/Updates
Table 160. Daan Gene Co., Ltd. Competitive Strengths & Weaknesses
Table 161. Shanghai ZJ Bio-Tech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 162. Shanghai ZJ Bio-Tech Co., Ltd. Major Business
Table 163. Shanghai ZJ Bio-Tech Co., Ltd. Mycoplasma Testing Product and Services
Table 164. Shanghai ZJ Bio-Tech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Shanghai ZJ Bio-Tech Co., Ltd. Recent Developments/Updates
Table 166. Shanghai ZJ Bio-Tech Co., Ltd. Competitive Strengths & Weaknesses
Table 167. Jiangsu Bioperfectus Technologies Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 168. Jiangsu Bioperfectus Technologies Co., Ltd. Major Business
Table 169. Jiangsu Bioperfectus Technologies Co., Ltd. Mycoplasma Testing Product and Services
Table 170. Jiangsu Bioperfectus Technologies Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Jiangsu Bioperfectus Technologies Co., Ltd. Recent Developments/Updates
Table 172. Jiangsu Bioperfectus Technologies Co., Ltd. Competitive Strengths & Weaknesses
Table 173. Vazyme Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 174. Vazyme Biotech Co., Ltd. Major Business
Table 175. Vazyme Biotech Co., Ltd. Mycoplasma Testing Product and Services
Table 176. Vazyme Biotech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Vazyme Biotech Co., Ltd. Recent Developments/Updates
Table 178. Vazyme Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 179. Yeasen Biotechnology (Shanghai) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 180. Yeasen Biotechnology (Shanghai) Co., Ltd. Major Business
Table 181. Yeasen Biotechnology (Shanghai) Co., Ltd. Mycoplasma Testing Product and Services
Table 182. Yeasen Biotechnology (Shanghai) Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Yeasen Biotechnology (Shanghai) Co., Ltd. Recent Developments/Updates
Table 184. Yeasen Biotechnology (Shanghai) Co., Ltd. Competitive Strengths & Weaknesses
Table 185. Beyotime Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 186. Beyotime Biotechnology Co., Ltd. Major Business
Table 187. Beyotime Biotechnology Co., Ltd. Mycoplasma Testing Product and Services
Table 188. Beyotime Biotechnology Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. Beyotime Biotechnology Co., Ltd. Recent Developments/Updates
Table 190. Beyotime Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 191. Shanghai Life-iLab Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 192. Shanghai Life-iLab Biotech Co., Ltd. Major Business
Table 193. Shanghai Life-iLab Biotech Co., Ltd. Mycoplasma Testing Product and Services
Table 194. Shanghai Life-iLab Biotech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. Shanghai Life-iLab Biotech Co., Ltd. Recent Developments/Updates
Table 196. Shanghai Life-iLab Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 197. Tiangen Biotech (Beijing) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 198. Tiangen Biotech (Beijing) Co., Ltd. Major Business
Table 199. Tiangen Biotech (Beijing) Co., Ltd. Mycoplasma Testing Product and Services
Table 200. Tiangen Biotech (Beijing) Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Tiangen Biotech (Beijing) Co., Ltd. Recent Developments/Updates
Table 202. Tiangen Biotech (Beijing) Co., Ltd. Competitive Strengths & Weaknesses
Table 203. Guangzhou Wondfo Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 204. Guangzhou Wondfo Biotech Co., Ltd. Major Business
Table 205. Guangzhou Wondfo Biotech Co., Ltd. Mycoplasma Testing Product and Services
Table 206. Guangzhou Wondfo Biotech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Guangzhou Wondfo Biotech Co., Ltd. Recent Developments/Updates
Table 208. Guangzhou Wondfo Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 209. Guangdong Hybribio Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 210. Guangdong Hybribio Biotech Co., Ltd. Major Business
Table 211. Guangdong Hybribio Biotech Co., Ltd. Mycoplasma Testing Product and Services
Table 212. Guangdong Hybribio Biotech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. Guangdong Hybribio Biotech Co., Ltd. Recent Developments/Updates
Table 214. Guangdong Hybribio Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 215. Global Key Players of Mycoplasma Testing Upstream (Raw Materials)
Table 216. Global Mycoplasma Testing Typical Customers
Table 1. World Mycoplasma Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Mycoplasma Testing Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Mycoplasma Testing Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Mycoplasma Testing Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Mycoplasma Testing Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Mycoplasma Testing Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Mycoplasma Testing Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Mycoplasma Testing Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Mycoplasma Testing Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Mycoplasma Testing Players in 2025
Table 12. World Mycoplasma Testing Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Mycoplasma Testing Company Evaluation Quadrant
Table 14. Head Office of Key Mycoplasma Testing Players
Table 15. Mycoplasma Testing Market: Company Product Type Footprint
Table 16. Mycoplasma Testing Market: Company Product Application Footprint
Table 17. Mycoplasma Testing Mergers & Acquisitions Activity
Table 18. United States VS China Mycoplasma Testing Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Mycoplasma Testing Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Mycoplasma Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Mycoplasma Testing Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Mycoplasma Testing Revenue Market Share (2021-2026)
Table 23. China Based Mycoplasma Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Mycoplasma Testing Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Mycoplasma Testing Revenue Market Share (2021-2026)
Table 26. Rest of World Based Mycoplasma Testing Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Mycoplasma Testing Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Mycoplasma Testing Revenue Market Share (2021-2026)
Table 29. World Mycoplasma Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Mycoplasma Testing Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Mycoplasma Testing Market Size by Type (2027-2032) & (USD Million)
Table 32. World Mycoplasma Testing Market Size by Sample Type, (USD Million), 2021 & 2025 & 2032
Table 33. World Mycoplasma Testing Market Size Value by Sample Type (2021-2026) & (USD Million)
Table 34. World Mycoplasma Testing Market Size by Sample Type (2027-2032) & (USD Million)
Table 35. World Mycoplasma Testing Market Size by Turnaround Time, (USD Million), 2021 & 2025 & 2032
Table 36. World Mycoplasma Testing Market Size Value by Turnaround Time (2021-2026) & (USD Million)
Table 37. World Mycoplasma Testing Market Size by Turnaround Time (2027-2032) & (USD Million)
Table 38. World Mycoplasma Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Mycoplasma Testing Market Size by Application (2021-2026) & (USD Million)
Table 40. World Mycoplasma Testing Market Size by Application (2027-2032) & (USD Million)
Table 41. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 42. Thermo Fisher Scientific Inc. Major Business
Table 43. Thermo Fisher Scientific Inc. Mycoplasma Testing Product and Services
Table 44. Thermo Fisher Scientific Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 46. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 47. Lonza Group AG Basic Information, Manufacturing Base and Competitors
Table 48. Lonza Group AG Major Business
Table 49. Lonza Group AG Mycoplasma Testing Product and Services
Table 50. Lonza Group AG Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Lonza Group AG Recent Developments/Updates
Table 52. Lonza Group AG Competitive Strengths & Weaknesses
Table 53. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 54. Merck KGaA Major Business
Table 55. Merck KGaA Mycoplasma Testing Product and Services
Table 56. Merck KGaA Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Merck KGaA Recent Developments/Updates
Table 58. Merck KGaA Competitive Strengths & Weaknesses
Table 59. Sartorius AG Basic Information, Manufacturing Base and Competitors
Table 60. Sartorius AG Major Business
Table 61. Sartorius AG Mycoplasma Testing Product and Services
Table 62. Sartorius AG Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Sartorius AG Recent Developments/Updates
Table 64. Sartorius AG Competitive Strengths & Weaknesses
Table 65. Hologic, Inc. Basic Information, Manufacturing Base and Competitors
Table 66. Hologic, Inc. Major Business
Table 67. Hologic, Inc. Mycoplasma Testing Product and Services
Table 68. Hologic, Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Hologic, Inc. Recent Developments/Updates
Table 70. Hologic, Inc. Competitive Strengths & Weaknesses
Table 71. Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table 72. Roche Diagnostics Major Business
Table 73. Roche Diagnostics Mycoplasma Testing Product and Services
Table 74. Roche Diagnostics Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Roche Diagnostics Recent Developments/Updates
Table 76. Roche Diagnostics Competitive Strengths & Weaknesses
Table 77. QIAGEN N.V. Basic Information, Manufacturing Base and Competitors
Table 78. QIAGEN N.V. Major Business
Table 79. QIAGEN N.V. Mycoplasma Testing Product and Services
Table 80. QIAGEN N.V. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. QIAGEN N.V. Recent Developments/Updates
Table 82. QIAGEN N.V. Competitive Strengths & Weaknesses
Table 83. ATCC Basic Information, Manufacturing Base and Competitors
Table 84. ATCC Major Business
Table 85. ATCC Mycoplasma Testing Product and Services
Table 86. ATCC Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. ATCC Recent Developments/Updates
Table 88. ATCC Competitive Strengths & Weaknesses
Table 89. Promega Corporation Basic Information, Manufacturing Base and Competitors
Table 90. Promega Corporation Major Business
Table 91. Promega Corporation Mycoplasma Testing Product and Services
Table 92. Promega Corporation Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Promega Corporation Recent Developments/Updates
Table 94. Promega Corporation Competitive Strengths & Weaknesses
Table 95. InvivoGen SAS Basic Information, Manufacturing Base and Competitors
Table 96. InvivoGen SAS Major Business
Table 97. InvivoGen SAS Mycoplasma Testing Product and Services
Table 98. InvivoGen SAS Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. InvivoGen SAS Recent Developments/Updates
Table 100. InvivoGen SAS Competitive Strengths & Weaknesses
Table 101. Minerva Biolabs GmbH Basic Information, Manufacturing Base and Competitors
Table 102. Minerva Biolabs GmbH Major Business
Table 103. Minerva Biolabs GmbH Mycoplasma Testing Product and Services
Table 104. Minerva Biolabs GmbH Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Minerva Biolabs GmbH Recent Developments/Updates
Table 106. Minerva Biolabs GmbH Competitive Strengths & Weaknesses
Table 107. PromoCell GmbH Basic Information, Manufacturing Base and Competitors
Table 108. PromoCell GmbH Major Business
Table 109. PromoCell GmbH Mycoplasma Testing Product and Services
Table 110. PromoCell GmbH Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. PromoCell GmbH Recent Developments/Updates
Table 112. PromoCell GmbH Competitive Strengths & Weaknesses
Table 113. Takara Bio Inc. Basic Information, Manufacturing Base and Competitors
Table 114. Takara Bio Inc. Major Business
Table 115. Takara Bio Inc. Mycoplasma Testing Product and Services
Table 116. Takara Bio Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Takara Bio Inc. Recent Developments/Updates
Table 118. Takara Bio Inc. Competitive Strengths & Weaknesses
Table 119. Otsuka Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 120. Otsuka Pharmaceutical Co., Ltd. Major Business
Table 121. Otsuka Pharmaceutical Co., Ltd. Mycoplasma Testing Product and Services
Table 122. Otsuka Pharmaceutical Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 124. Otsuka Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 125. Shimadzu Diagnostics Corporation Basic Information, Manufacturing Base and Competitors
Table 126. Shimadzu Diagnostics Corporation Major Business
Table 127. Shimadzu Diagnostics Corporation Mycoplasma Testing Product and Services
Table 128. Shimadzu Diagnostics Corporation Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Shimadzu Diagnostics Corporation Recent Developments/Updates
Table 130. Shimadzu Diagnostics Corporation Competitive Strengths & Weaknesses
Table 131. Seegene Inc. Basic Information, Manufacturing Base and Competitors
Table 132. Seegene Inc. Major Business
Table 133. Seegene Inc. Mycoplasma Testing Product and Services
Table 134. Seegene Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Seegene Inc. Recent Developments/Updates
Table 136. Seegene Inc. Competitive Strengths & Weaknesses
Table 137. Bioneer Corporation Basic Information, Manufacturing Base and Competitors
Table 138. Bioneer Corporation Major Business
Table 139. Bioneer Corporation Mycoplasma Testing Product and Services
Table 140. Bioneer Corporation Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Bioneer Corporation Recent Developments/Updates
Table 142. Bioneer Corporation Competitive Strengths & Weaknesses
Table 143. SolGent Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 144. SolGent Co., Ltd. Major Business
Table 145. SolGent Co., Ltd. Mycoplasma Testing Product and Services
Table 146. SolGent Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. SolGent Co., Ltd. Recent Developments/Updates
Table 148. SolGent Co., Ltd. Competitive Strengths & Weaknesses
Table 149. Sansure Biotech Inc. Basic Information, Manufacturing Base and Competitors
Table 150. Sansure Biotech Inc. Major Business
Table 151. Sansure Biotech Inc. Mycoplasma Testing Product and Services
Table 152. Sansure Biotech Inc. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Sansure Biotech Inc. Recent Developments/Updates
Table 154. Sansure Biotech Inc. Competitive Strengths & Weaknesses
Table 155. Daan Gene Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 156. Daan Gene Co., Ltd. Major Business
Table 157. Daan Gene Co., Ltd. Mycoplasma Testing Product and Services
Table 158. Daan Gene Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Daan Gene Co., Ltd. Recent Developments/Updates
Table 160. Daan Gene Co., Ltd. Competitive Strengths & Weaknesses
Table 161. Shanghai ZJ Bio-Tech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 162. Shanghai ZJ Bio-Tech Co., Ltd. Major Business
Table 163. Shanghai ZJ Bio-Tech Co., Ltd. Mycoplasma Testing Product and Services
Table 164. Shanghai ZJ Bio-Tech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Shanghai ZJ Bio-Tech Co., Ltd. Recent Developments/Updates
Table 166. Shanghai ZJ Bio-Tech Co., Ltd. Competitive Strengths & Weaknesses
Table 167. Jiangsu Bioperfectus Technologies Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 168. Jiangsu Bioperfectus Technologies Co., Ltd. Major Business
Table 169. Jiangsu Bioperfectus Technologies Co., Ltd. Mycoplasma Testing Product and Services
Table 170. Jiangsu Bioperfectus Technologies Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Jiangsu Bioperfectus Technologies Co., Ltd. Recent Developments/Updates
Table 172. Jiangsu Bioperfectus Technologies Co., Ltd. Competitive Strengths & Weaknesses
Table 173. Vazyme Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 174. Vazyme Biotech Co., Ltd. Major Business
Table 175. Vazyme Biotech Co., Ltd. Mycoplasma Testing Product and Services
Table 176. Vazyme Biotech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Vazyme Biotech Co., Ltd. Recent Developments/Updates
Table 178. Vazyme Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 179. Yeasen Biotechnology (Shanghai) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 180. Yeasen Biotechnology (Shanghai) Co., Ltd. Major Business
Table 181. Yeasen Biotechnology (Shanghai) Co., Ltd. Mycoplasma Testing Product and Services
Table 182. Yeasen Biotechnology (Shanghai) Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Yeasen Biotechnology (Shanghai) Co., Ltd. Recent Developments/Updates
Table 184. Yeasen Biotechnology (Shanghai) Co., Ltd. Competitive Strengths & Weaknesses
Table 185. Beyotime Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 186. Beyotime Biotechnology Co., Ltd. Major Business
Table 187. Beyotime Biotechnology Co., Ltd. Mycoplasma Testing Product and Services
Table 188. Beyotime Biotechnology Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. Beyotime Biotechnology Co., Ltd. Recent Developments/Updates
Table 190. Beyotime Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 191. Shanghai Life-iLab Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 192. Shanghai Life-iLab Biotech Co., Ltd. Major Business
Table 193. Shanghai Life-iLab Biotech Co., Ltd. Mycoplasma Testing Product and Services
Table 194. Shanghai Life-iLab Biotech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. Shanghai Life-iLab Biotech Co., Ltd. Recent Developments/Updates
Table 196. Shanghai Life-iLab Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 197. Tiangen Biotech (Beijing) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 198. Tiangen Biotech (Beijing) Co., Ltd. Major Business
Table 199. Tiangen Biotech (Beijing) Co., Ltd. Mycoplasma Testing Product and Services
Table 200. Tiangen Biotech (Beijing) Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Tiangen Biotech (Beijing) Co., Ltd. Recent Developments/Updates
Table 202. Tiangen Biotech (Beijing) Co., Ltd. Competitive Strengths & Weaknesses
Table 203. Guangzhou Wondfo Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 204. Guangzhou Wondfo Biotech Co., Ltd. Major Business
Table 205. Guangzhou Wondfo Biotech Co., Ltd. Mycoplasma Testing Product and Services
Table 206. Guangzhou Wondfo Biotech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Guangzhou Wondfo Biotech Co., Ltd. Recent Developments/Updates
Table 208. Guangzhou Wondfo Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 209. Guangdong Hybribio Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 210. Guangdong Hybribio Biotech Co., Ltd. Major Business
Table 211. Guangdong Hybribio Biotech Co., Ltd. Mycoplasma Testing Product and Services
Table 212. Guangdong Hybribio Biotech Co., Ltd. Mycoplasma Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. Guangdong Hybribio Biotech Co., Ltd. Recent Developments/Updates
Table 214. Guangdong Hybribio Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 215. Global Key Players of Mycoplasma Testing Upstream (Raw Materials)
Table 216. Global Mycoplasma Testing Typical Customers
LIST OF FIGURES
Figure 1. Mycoplasma Testing Picture
Figure 2. World Mycoplasma Testing Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Mycoplasma Testing Total Revenue (2021-2032) & (USD Million)
Figure 4. World Mycoplasma Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Mycoplasma Testing Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Mycoplasma Testing Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Mycoplasma Testing Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Mycoplasma Testing Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Mycoplasma Testing Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Mycoplasma Testing Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Mycoplasma Testing Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Mycoplasma Testing Revenue (2021-2032) & (USD Million)
Figure 13. Mycoplasma Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Mycoplasma Testing Consumption Value (2021-2032) & (USD Million)
Figure 16. World Mycoplasma Testing Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Mycoplasma Testing Consumption Value (2021-2032) & (USD Million)
Figure 18. China Mycoplasma Testing Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Mycoplasma Testing Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Mycoplasma Testing Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Mycoplasma Testing Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Mycoplasma Testing Consumption Value (2021-2032) & (USD Million)
Figure 23. India Mycoplasma Testing Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Mycoplasma Testing by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Mycoplasma Testing Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Mycoplasma Testing Markets in 2025
Figure 27. United States VS China: Mycoplasma Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Mycoplasma Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Mycoplasma Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Mycoplasma Testing Market Size Market Share by Type in 2025
Figure 31. Nucleic Acid Amplification Testing
Figure 32. Culture-based Testing
Figure 33. Immunological and Biochemical Testing
Figure 34. World Mycoplasma Testing Market Size Market Share by Type (2021-2032)
Figure 35. World Mycoplasma Testing Market Size by Sample Type, (USD Million), 2021 & 2025 & 2032
Figure 36. World Mycoplasma Testing Market Size Market Share by Sample Type in 2025
Figure 37. Clinical Specimen Testing
Figure 38. Cell Culture Sample Testing
Figure 39. Biopharmaceutical Process Sample Testing
Figure 40. World Mycoplasma Testing Market Size Market Share by Sample Type (2021-2032)
Figure 41. World Mycoplasma Testing Market Size by Turnaround Time, (USD Million), 2021 & 2025 & 2032
Figure 42. World Mycoplasma Testing Market Size Market Share by Turnaround Time in 2025
Figure 43. Rapid Testing(≤4 Hours)
Figure 44. Standard Testing(>4–48 Hours)
Figure 45. Extended Testing(>48 Hours)
Figure 46. World Mycoplasma Testing Market Size Market Share by Turnaround Time (2021-2032)
Figure 47. World Mycoplasma Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Mycoplasma Testing Market Size Market Share by Application in 2025
Figure 49. Clinical Infection Diagnosis
Figure 50. Cell Culture Contamination Monitoring
Figure 51. Biopharmaceutical Quality Control
Figure 52. Other
Figure 53. World Mycoplasma Testing Market Size Market Share by Application (2021-2032)
Figure 54. Mycoplasma Testing Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Mycoplasma Testing Picture
Figure 2. World Mycoplasma Testing Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Mycoplasma Testing Total Revenue (2021-2032) & (USD Million)
Figure 4. World Mycoplasma Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Mycoplasma Testing Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Mycoplasma Testing Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Mycoplasma Testing Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Mycoplasma Testing Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Mycoplasma Testing Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Mycoplasma Testing Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Mycoplasma Testing Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Mycoplasma Testing Revenue (2021-2032) & (USD Million)
Figure 13. Mycoplasma Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Mycoplasma Testing Consumption Value (2021-2032) & (USD Million)
Figure 16. World Mycoplasma Testing Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Mycoplasma Testing Consumption Value (2021-2032) & (USD Million)
Figure 18. China Mycoplasma Testing Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Mycoplasma Testing Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Mycoplasma Testing Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Mycoplasma Testing Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Mycoplasma Testing Consumption Value (2021-2032) & (USD Million)
Figure 23. India Mycoplasma Testing Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Mycoplasma Testing by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Mycoplasma Testing Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Mycoplasma Testing Markets in 2025
Figure 27. United States VS China: Mycoplasma Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Mycoplasma Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Mycoplasma Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Mycoplasma Testing Market Size Market Share by Type in 2025
Figure 31. Nucleic Acid Amplification Testing
Figure 32. Culture-based Testing
Figure 33. Immunological and Biochemical Testing
Figure 34. World Mycoplasma Testing Market Size Market Share by Type (2021-2032)
Figure 35. World Mycoplasma Testing Market Size by Sample Type, (USD Million), 2021 & 2025 & 2032
Figure 36. World Mycoplasma Testing Market Size Market Share by Sample Type in 2025
Figure 37. Clinical Specimen Testing
Figure 38. Cell Culture Sample Testing
Figure 39. Biopharmaceutical Process Sample Testing
Figure 40. World Mycoplasma Testing Market Size Market Share by Sample Type (2021-2032)
Figure 41. World Mycoplasma Testing Market Size by Turnaround Time, (USD Million), 2021 & 2025 & 2032
Figure 42. World Mycoplasma Testing Market Size Market Share by Turnaround Time in 2025
Figure 43. Rapid Testing(≤4 Hours)
Figure 44. Standard Testing(>4–48 Hours)
Figure 45. Extended Testing(>48 Hours)
Figure 46. World Mycoplasma Testing Market Size Market Share by Turnaround Time (2021-2032)
Figure 47. World Mycoplasma Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Mycoplasma Testing Market Size Market Share by Application in 2025
Figure 49. Clinical Infection Diagnosis
Figure 50. Cell Culture Contamination Monitoring
Figure 51. Biopharmaceutical Quality Control
Figure 52. Other
Figure 53. World Mycoplasma Testing Market Size Market Share by Application (2021-2032)
Figure 54. Mycoplasma Testing Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
